SpringWorks Therapeutics

Biotech & Life Sciences · New York City, United States · Founded 2017 · IPO 2019

SpringWorks Therapeutics is a clinical stage biopharmaceutical company focused on developing and commercializing precision medicines for patients with rare diseases and cancer. The company employs a precision medicine approach, which means they tailor treatments based on the genetic and molecular profile of the disease. This approach aims to improve the efficacy and safety of treatments for underserved patient populations suffering from devastating conditions. SpringWorks operates in the biopharmaceutical market, targeting both rare diseases and oncology. Their business model involves acquiring, developing, and commercializing innovative therapies. Revenue is generated through the successful development and commercialization of these therapies, often in collaboration with other pharmaceutical companies. The company serves a niche market of patients with specific genetic profiles, offering them potentially life-changing treatments that are not widely available. SpringWorks is actively involved in clinical trials, including Phase 1b and 2 studies, to evaluate the efficacy and safety of their drug candidates. Keywords: precision medicine, biopharmaceutical, rare diseases, cancer, clinical trials, genetic profiling, oncology, drug development, underserved patients, innovative therapies.

Valuation $3.26B

Revenue $192M

Total funding $100–500M

Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Featured in

News Beeline Medicines launches with $300M and five BMS drugs to target lupus and beyond Apr 15, 2026

Investors

16 investors on SpringWorks Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 8 investors entered at this stage

Pfizer

Bain Capital

OrbiMed

LifeArc

Perceptive Advisors

ArrowMark Partners

Samsara BioCapital

GSK

Series B+ 8 investors entered at this stage

GSK

Perceptive Advisors

EcoR1 Capital

ArrowMark Partners

Deerfield

Samsara BioCapital

Boxer Capital

Invus

Global footprint

Where SpringWorks Therapeutics has talent and traffic

Workforce by country

5 countries with
team presence

🇺🇸 United States92.8%

🇩🇪 Germany4.6%

🇨🇭 Switzerland1%

🇮🇹 Italy0.7%

🇬🇧 United Kingdom0.7%

5 countries shown

Web traffic by country

14K monthly visits
across markets

🇺🇸 United States92.1%

🇮🇳 India9.3%

Top 2 markets shown

Talent graph

The shape of SpringWorks Therapeutics's talent

Dealroom maps SpringWorks Therapeutics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

32 standout operatorsDealroom-flagged across the org

1 AI specialistpinpointed by name

352 employees mappedperson by person

DimensionScore

AI Talentlive

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock SpringWorks Therapeutics's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$26M patent portfolio · 58 active families

Estimated portfolio value

$26M

0.81% of market cap · 5.5× larger than top peer Repare Therapeutics ($5M)

58 active patent families

Where SpringWorks Therapeutics innovates Cancer researchCarcinosisDiseaseInternal medicineNeurofibra

Where SpringWorks Therapeutics concentrates vs peers

Each axis is a top-10 topic across SpringWorks Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about SpringWorks Therapeutics

An AI-synthesized read of the highest-engagement posts about SpringWorks Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SpringWorks Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles